Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Arterial Infusion Chemotherapy”

178 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 178 results

Not applicableLooking for participantsNCT06519578
What this trial is testing

Prospective Real-World Study of HAIC With Raltitrexed or 5-Fluorouracil for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
RenJi Hospital 1,115
Large-scale testing (Phase 3)Study completedNCT02973685
What this trial is testing

HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 315
Large-scale testing (Phase 3)Looking for participantsNCT06201065
What this trial is testing

FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 200
Post-approval studies (Phase 4)UnknownNCT05416073
What this trial is testing

Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaTransarterial ChemoembolizationHepatic Arterial Infusion Chemotherapy+1 more
The Second Affiliated Hospital of Chongqing Medical University 70
Testing effectiveness (Phase 2)Study completedNCT04217954
What this trial is testing

HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC

Who this might be right for
Advanced Biliary Tract Cancer
Peking University 32
Large-scale testing (Phase 3)UnknownNCT03780049
What this trial is testing

HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 304
Testing effectiveness (Phase 2)WithdrawnNCT03780634
What this trial is testing

HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University
Not applicableActive Not RecruitingNCT06199232
What this trial is testing

Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed From Standard Systemic Treatment

Who this might be right for
Liver Metastasis Colon CancerctDNA GenotypeMSS+1 more
Peking University 47
Testing effectiveness (Phase 2)UnknownNCT06293287
What this trial is testing

Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy

Who this might be right for
Radial Artery Occlusion
Zhongshan Hospital (Xiamen), Fudan University 156
Testing effectiveness (Phase 2)UnknownNCT04961918
What this trial is testing

The Efficacy of Hepatic Arterial Infusion Chemotherapy (HAIC) Combine Lenvatinib and Durvalumab (HILL) in Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 36
Testing effectiveness (Phase 2)Looking for participantsNCT06285019
What this trial is testing

Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 65
Not applicableStudy completedNCT05121571
What this trial is testing

The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 114
Early research (Phase 1)Study completedNCT06184841
What this trial is testing

HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell Carcinoma

Who this might be right for
Hepatic Arterial Infusion ChemotherapyLiver MetastasesEsophageal Squamous Cell Carcinoma
Peking University Cancer Hospital & Institute 25
Large-scale testing (Phase 3)UnknownNCT05866172
What this trial is testing

HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 264
Large-scale testing (Phase 3)Not Yet RecruitingNCT07284394
What this trial is testing

Liver-directed Chemotherapy After Surgery of Liver Metastases of Colorectal Cancer in Patients With High Risk of Recurrence of Their Disease

Who this might be right for
Colorectal Adenocarcinoma Metastatic in the LiverColorectal Cancer
UNICANCER 272
Testing effectiveness (Phase 2)Study completedNCT06071052
What this trial is testing

TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens

Who this might be right for
Liver Metastasis Colon Cancer
First Affiliated Hospital, Sun Yat-Sen University 21
Not applicableStudy completedNCT06435013
What this trial is testing

Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC

Who this might be right for
Hepatocellular CarcinomaLenvatinib
Sun Yat-sen University 208
Testing effectiveness (Phase 2)UnknownNCT04135690
What this trial is testing

HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06859684
What this trial is testing

Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)HAICDurvalumab
West China Hospital 25
Testing effectiveness (Phase 2)UnknownNCT04003792
What this trial is testing

Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM.

Who this might be right for
Liver Metastasis Colon Cancer
Rabin Medical Center 49
Load More Results